Jennifer Chow
Chief Executive, Managing Director / Chimeric Therapeutics
Jennifer Chow has over 20 years of commercial strategy and marketing experience with a focus on cellular therapy, hematology and oncology.
Prior to joining Chimeric Therapeutics in December 2020 and becoming chief executive & managing director in July 2021, Ms Chow was the head of global marketing, analytics and commercial operations at global company Kite Pharmaceuticals (acquired by Gilead Sciences in 2017), global cell therapy commercial lead at Celgene Corporation, and worked at Roche, Nycomed/Takeda and Schering Canada.
